Prospects for the Development of a Dengue Vaccine
Open Access
- 10 August 2016
- journal article
- Published by Peertechz Publications Private Limited in Journal of Vaccines and Immunology
- Vol. 2 (1), 015-018
- https://doi.org/10.17352/jvi.000015
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.The Journal of Infectious Diseases, 2016
- Symptomatic Dengue in Children in 10 Asian and Latin American CountriesThe New England Journal of Medicine, 2016
- Next generation dengue vaccines: A review of the preclinical development pipelineVaccine, 2015
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic DiseaseThe New England Journal of Medicine, 2015
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin AmericaThe New England Journal of Medicine, 2015
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trialThe Lancet, 2014
- Latest developments and future directions in dengue vaccinesTherapeutic Advances in Vaccines, 2013